CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Retained Earnings
Beginning Balance (in shares) at Sep. 30, 2022		13,047
Beginning balance at Sep. 30, 2022	$ 92,060	$ 13	$ 91,057	$ 990
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance and fair value adjustment of common stock in business combination (in shares)		527
Issuance and fair value adjustment of common stock in business combination	7,000	$ 1	6,999
Expense related to director restricted stock units	180		180
Expense related to employee stock-based compensation	372		372
Exercise of stock options (in shares)		250
Exercise of stock options	0		0
Common stock surrendered for the exercise of stock options (in shares)		(67)
Common stock surrendered for the exercise of stock options	(650)		(650)
Net income	1,547			1,547
Ending Balance (in shares) at Dec. 31, 2022		13,757
Ending balance at Dec. 31, 2022	$ 100,509	$ 14	97,958	2,537
Beginning Balance (in shares) at Sep. 30, 2023	13,950	13,950
Beginning balance at Sep. 30, 2023	$ 102,439	$ 14	99,974	2,451
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Expense related to director restricted stock units	80		80
Expense related to employee stock options	$ 540		540
Exercise of stock options (in shares)	220	220
Exercise of stock options	$ 261		261
Common stock surrendered for the exercise of stock options (in shares)		(65)
Common stock surrendered for the exercise of stock options	(669)		(669)
Net income	$ 2,151			2,151
Ending Balance (in shares) at Dec. 31, 2023	14,105	14,105
Ending balance at Dec. 31, 2023	$ 104,802	$ 14	$ 100,186	$ 4,602